Premium
Transporters for Drug Delivery and as Drug Targets in Parasitic Protozoa
Author(s) -
Landfear S M
Publication year - 2010
Publication title -
clinical pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.941
H-Index - 188
eISSN - 1532-6535
pISSN - 0009-9236
DOI - 10.1038/clpt.2009.116
Subject(s) - permease , protozoa , drug , biology , drug development , parasite hosting , drug delivery , transporter , pharmacology , microbiology and biotechnology , chemistry , biochemistry , gene , organic chemistry , world wide web , computer science
Parasitic protozoa cause devastating diseases across large regions of the globe, but a lack of economic incentives has resulted in the limited development of drugs against these “neglected diseases.” Transporters expressed in the plasma membranes of these parasites offer potential for the development of new drugs. These permeases could be employed in two distinct strategies for drug development: (i) targeting selective delivery of drugs to the parasite and (ii) developing drugs that inhibit essential parasite permeases. Clinical Pharmacology & Therapeutics (2010) 87 1, 122–125. doi: 10.1038/clpt.2009.116